New Zealand Pharmaceuticals (NZP) manufactures pharmaceutical intermediates and diagnostic products for pharmaceutical and biotechnology companies
Newomics Inc., a biotechnology company in the San Francisco Bay Area, commercializes innovative (New) and integrative (Omics) platforms and solutions for personalized healthcare. Our proprietary ...
The company produces custom made vaccines and diagnostics for cows, pigs, whitetail deer, and other species.
Nightingale’s platform makes comprehensive biomarker profiling affordable for biobanks and cohorts of any scale. The platform provides over 220 biomarkers in a single experiment. Amino acids, ...
The Novacyt Group is a leader in the field of cellular diagnostics with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform ...
Develops Noviplex Cards for analysis by mass spectrometry which can quantify picogram amounts of compounds on the plasma collection disc.
Small Molecules, Diagnostics
OmniVis’ hardware device and consumable test kit (razor/razorblade model) attaches to a smartphone and reduces the detection process from 3-5 days down to 30 minutes, accurately and affordably. ...
Oncgnostics developps in vitro diagnostic tests for all areas of cancer diagnostics.
Cancer treatment and diagnosis using liquid biopsies for rapid screening.
The OneOme® platform was co-developed and exclusively licensed from Mayo Clinic to bring pharmacogenomics into routine clinical care. The OneOme RightMed pharmacogenomic test is ...
OnsiteGene Inc. is a biomedical technology company developing on-site genetic testing based on a new sample prep and qPCR process.
Biologics, Vaccines, Diagnostics, etc
Orion Diagnostica builds well-being by specialising in accurate and affordable clinical diagnostic and hygiene monitoring tests, which are easy to use and provide fast results.
Owlstone Medical is developing a non-invasive breathalyzer diagnostic for cancer, infectious disease and inflammatory disease.
A breathalyzer for disease. Owlstone Medical has developed Breath Biopsy® technology to identify non-invasive VOC biomarkers in breath.
Develops novel protein biotherapeutics for a pipeline of products ranging from infectious disease vaccines and adjuvants to small molecule therapeutics.
PathoFinder offers molecular diagnostics for syndromic infectious disease panels.
Perosphere Technologies is a private medical technologies company focused on developing coagulation diagnostics and medical device-based drug delivery systems.